Anteris Technologies

Update in progress

AVR.AX (ASX)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Anteris Technologies Global Corp is a structural heart company focused on minimally invasive devices for heart valve disease. Its DurAVR transcatheter aortic valve treats severe aortic stenosis and aims to mimic native valve function. ADAPT anti-calcification tissue creates durable bioscaffolds from xenograft tissue for valve repair and other surgeries. ComASUR is a balloon-expanded delivery system with a reinforced steerable catheter for precise, safe navigation of the heart. Based in Toowong, Australia.

Company score

Sentiment: 0.48; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.01; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.33; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.13; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.13; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.30; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive